Ado-trastuzumab emtansine and Emend (Fosaprepitant)
Determining the interaction of Ado-trastuzumab emtansine and Emend (Fosaprepitant) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-Trastuzumab Emtansine
Generic Name: fosaprepitant
Brand name: Emend for Injection
Synonyms: Fosaprepitant
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine-Emend for Injection
- Ado-trastuzumab emtansine-Emend Intravenous
- Ado-trastuzumab emtansine-Emflaza
- Ado-trastuzumab emtansine-Emflaza (Deflazacort Oral Suspension)
- Ado-trastuzumab emtansine-Emflaza (Deflazacort Tablets)
- Ado-trastuzumab emtansine-Emicizumab
- Emend (Fosaprepitant)-Ado-trastuzumab emtansine Intravenous
- Emend (Fosaprepitant)-Adox Pak 2/100
- Emend (Fosaprepitant)-Adoxa
- Emend (Fosaprepitant)-Adoxa CK
- Emend (Fosaprepitant)-Adoxa Pak
- Emend (Fosaprepitant)-Adoxa Pak 1/100